Nettoinventarwert (NAV)
| 22.28 EUR | -0.70 EUR | -3.04 % |
|---|
| Vortag | 22.98 EUR | Datum | 05.11.2026 |
Leverage Shares 5x Long DAX ETP Securities Kurs - 1 Jahr
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Raydium ETP | CH1480821391 | 185.82% | |
| 21Shares Stacks ETP | CH1258969042 | 154.88% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 130.82% | |
| 21Shares Arbitrum ETP | CH1304867463 | 115.43% | |
| 21Shares Injective Staking ETP | CH1360612134 | 84.05% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 139.35% | |
| 21Shares Raydium ETP | CH1480821391 | 115.87% | |
| 21Shares Injective Staking ETP | CH1360612134 | 100.05% | |
| 21Shares Uniswap ETP | CH1135202096 | 91.61% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 81.05% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 93.41% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 88.97% | |
| 21Shares Raydium ETP | CH1480821391 | 31.07% | |
| 21Shares Uniswap ETP | CH1135202096 | 21.59% | |
| 21Shares Injective Staking ETP | CH1360612134 | 17.79% |
Fundamentaldaten
| Valor | |
| ISIN | XS2472331995 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 06.06.2022 |
| Kategorie | Trading - Leveraged/Inverse Aktien |
| Währung | EUR |
| Volumen | 635’591.98 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 09.11.2026 |
Anlagepolitik
So investiert der Leverage Shares 5x Long DAX ETP Securities: The objective of the ETP Securities is to provide 3 times the value of the daily performance of the iShares Core DAX UCITS ETF (DE) , net of fees and expenses. The ETP securities seek to pursue the 3x Long Germany Investment Strategy (the "Investment Strategy") which provides exposure to 3 times the daily performance of the iShares Core DAX UCITS ETF (DE) (the “Reference Asset”).